Satish Joshi

Dr. Satish Joshi is Vice President of Peptide Chemistry at Amytrx and oversees the company’s novel peptide synthesis, development and large-scale manufacturing methods. Dr. Joshi has over 20 years of experience in peptide discovery, with extensive expertise in peptide medicinal chemistry and peptide drug delivery. Dr. Joshi is an experienced executive, serial entrepreneur and co-founder of Star Biochemicals, acquired by Mallinckrodt; Peptisyntha, acquired by Solvay; and STAR Bio Solutions, a company specializing in peptide APIs. Dr. Joshi received his Ph.D. in Organic Chemistry from the Department of Chemical Technology in India.